BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29630101)

  • 1. Efficacy of computed tomography-guided implantation of 125I seeds in the treatment of refractory malignant tumors accompanied with cancer pain and its influence on tumor markers in the serum.
    Duan F; Su XL; Wei ZX; Kong DW; Huang TY; Wang S
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1595-1601. PubMed ID: 29630101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of chemotherapy combined with Chinese herbal medicine Kangliu Zengxiao decoction on tumor markers of patients with advanced non-small-cell lung cancer: a randomized, controlled trial].
    Yan GY; Xu ZY; Deng HB; Wan ZY; Zhang L; Zhu JY
    Zhong Xi Yi Jie He Xue Bao; 2011 May; 9(5):525-30. PubMed ID: 21565138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis on the Efficacy of Bronchial Artery Chemoembolization Combined with 125I Seed Implantation in the Therapy of Advanced Non-Small-Cell Lung Cancer Based on the Medical Database.
    Xie P; He L; Zhang Y
    Biomed Res Int; 2022; 2022():7376844. PubMed ID: 35782072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Evaluation of CT Imaging Big Data-Assisted Arterial Chemoembolization Combined with
    Xie P; Zhang Y; He L
    Comput Math Methods Med; 2022; 2022():3472982. PubMed ID: 35872936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic utility of serum and pleural fluid carcinoembryonic antigen, neuron-specific enolase, and cytokeratin 19 fragments in patients with effusions from primary lung cancer.
    Lee JH; Chang JH
    Chest; 2005 Oct; 128(4):2298-303. PubMed ID: 16236887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of malignant pericarditis: a single centre experience.
    Pawlak Cieślik A; Szturmowicz M; Fijałkowska A; Gątarek J; Gralec R; Błasińska-Przerwa K; Szczepulska-Wójcik E; Skoczylas A; Bilska A; Tomkowski W
    Kardiol Pol; 2012; 70(11):1147-53. PubMed ID: 23180523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility of haptoglobin in combination with CEA, NSE and CYFRA21-1 for diagnosis of lung cancer.
    Wang B; He YJ; Tian YX; Yang RN; Zhu YR; Qiu H
    Asian Pac J Cancer Prev; 2014; 15(22):9611-4. PubMed ID: 25520076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of serum tumor markers in patients with lung cancer.
    Hatzakis KD; Froudarakis ME; Bouros D; Tzanakis N; Karkavitsas N; Siafakas NM
    Respiration; 2002; 69(1):25-9. PubMed ID: 11844959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of diagnostic value of four tumor markers in bronchoalveolar lavage fluid of peripheral lung cancer.
    Li J; Chen P; Mao CM; Tang XP; Zhu LR
    Asia Pac J Clin Oncol; 2014 Jun; 10(2):141-8. PubMed ID: 23551358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoembryonic antigen, neuron-specific enolase and cytokeratin fragment 19 (CYFRA 21-1) levels in induced sputum of lung cancer patients.
    Hillas G; Moschos C; Dimakou K; Vlastos F; Avgeropoulou S; Christakopoulou I; Rasidakis A; Bakakos P
    Scand J Clin Lab Invest; 2008; 68(7):542-7. PubMed ID: 19378425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The important role of circulating CYFRA21-1 in metastasis diagnosis and prognostic value compared with carcinoembryonic antigen and neuron-specific enolase in lung cancer patients.
    Zhang L; Liu D; Li L; Pu D; Zhou P; Jing Y; Yu H; Wang Y; Zhu Y; He Y; Li Y; Zhao S; Qiu Z; Li W
    BMC Cancer; 2017 Feb; 17(1):96. PubMed ID: 28152979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions.
    Ferrer J; Villarino MA; Encabo G; Felip E; Bermejo B; Vilà S; Orriols R
    Cancer; 1999 Oct; 86(8):1488-95. PubMed ID: 10526277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical observations on the association between diagnosis of lung cancer and serum tumor markers in combination.
    Wang WJ; Tao Z; Gu W; Sun LH
    Asian Pac J Cancer Prev; 2013; 14(7):4369-71. PubMed ID: 23992005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer.
    Jiang ZF; Wang M; Xu JL
    Life Sci; 2018 Feb; 194():1-6. PubMed ID: 29247745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study.
    Ebert W; Dienemann H; Fateh-Moghadam A; Scheulen M; Konietzko N; Schleich T; Bombardieri E
    Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):189-99. PubMed ID: 7518259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of serum tumor markers combined with dual-source CT in the diagnosis of lung cancer.
    Shan Y; Yin X; Zhao N; Wang J; Yang S
    Minerva Med; 2023 Dec; 114(6):795-801. PubMed ID: 33764713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of the tumour markers, carcinoembryonic antigen (CEA), cytokeratin marker (CYFRA 21-1) and neuron-specific enolase (NSE) in the differentiation of malignant from benign solitary pulmonary lesions.
    Seemann MD; Beinert T; Fürst H; Fink U
    Lung Cancer; 1999 Dec; 26(3):149-55. PubMed ID: 10598925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of chest radiography, computed tomography and tumour markers in the differentiation of malignant from benign solitary pulmonary lesions.
    Seemann MD; Seemann O; Dienemann H; Schalhorn A; Prime G; Fink U
    Eur J Med Res; 1999 Aug; 4(8):313-27. PubMed ID: 10471543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of tumor markers series of hydrothorax in differential diagnosis of pleural effusion].
    Liu YQ; Zhang HL; Gao WJ; Lan X; Yuan BJ; Zou JM
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2008 Jan; 26(1):34-8. PubMed ID: 18302890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited.
    Ma S; Shen L; Qian N; Chen K
    Cancer Biomark; 2011-2012; 10(3-4):155-62. PubMed ID: 22674301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.